Straits Times Index
3,403.14 -7.67 (-0.22%) Nikkei
40,881.42 -30.95 (-0.08%) Hang Seng
17,537.04 -262.57 (-1.48%) FTSE 100
8,203.93 -37.33 (-0.45%) Bitcoin USD
55,454.84 -2,255.57 (-3.91%) CMC Crypto 200
1,150.43 -58.26 (-4.82%)
AGC Inc (SHJ.MU)
| Previous close | 30.40 |
| Open | 30.20 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 30.20 - 30.20 |
| 52-week range | 30.20 - 35.80 |
| Volume | |
| Avg. volume | 6 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 08 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Business WireThe AGC Group Obtains Its First Cradle to Cradle Certified® for Mirox MNGE Interior Glass Products in Asia
TOKYO, May 13, 2024--AGC Glass Asia’s Mirox MNGE, a low lead mirror, is awarded with Cradle to Cradle Certified® at the Bronze level based on version 3.1.
Business WireThe AGC Group Makes Donations to Help Victims of Eastern Taiwan Earthquake
TOKYO, April 19, 2024--The AGC Group had announced that it will donate 3 million yen to help those affected by the eastern Taiwan Earthquake.
- MediaOutReach
AGC Biologics Announces Plans for New Manufacturing Site in Yokohama Japan
The new four-story 20,000 m² facility will feature mammalian cell culture, messenger RNA and cell therapy services and be operational in 2026SEATTLE, USA - News Direct - 04 January 2024 - AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced plans to construct a new manufacturing facility at AGC Inc.’s Yokohama Technical Center in Japan. The new site is a part of the CDMO’s strategic growth strategy to create more high-quali
